Key Competitors - Africa Injectable Drugs Industry

Injectable pharmaceutical drug delivery system can be used as an alternative to oral drug delivery system. An injection is considered a form of parenteral drug administration, and it allows the medication to be absorbed more rapidly.

As of 2022, the Africa Injectable Drugs Market is estimated to be valued at U.S. $ 284.5 Million and is expected to exhibit a CAGR of 4.7% during the years (2022-2030)

Major Players in the Africa Injectable Drugs Industry:

1) Apotex Inc.

Apotex Inc. is a pharmaceutical corporation based in Canada. Apotex is the largest producer of generic drugs in Canada. The company manufactures and sells generic medications for diseases like cancer, diabetes, high cholesterol and blood pressure. The company was founded in the year 1974 and the headquarters are located in Toronto, Ontario, Canada. The company was founded by Barry Sherman.

In July, 2022 Apotex Inc. announced the launch of APO-Apixaban tablets. Canada’s first generic alternative to Eliquis. 

2) Hikma Pharmaceuticals

Hikma Pharmaceuticals Plc. Is a multinational pharmaceutical company that was the first Arab company to export pharmaceutical products in the U.S. The Company was founded in the year 1978 by Samih Darwazah. The Headquarters are located in London, England, UK. Products manufactured include Amoclan, Prograf, and Suprax.

In January 2023, The Company launched Naloxone Hydrochloride Injection, in prefilled syringe form, which is used for the emergency treatment of opioid overdose Hikma Pharmaceuticals

3) Sun Pharmaceutical Industries Limited

Sun Pharma is an Indian multinational pharmaceutical company. Sun Pharma is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Sun Pharma was founded in the year 1983, and the headquarters are located in Mumbai, India. The company was founded by Dilip Shanghvi.

In January 2023, Sun Pharma completed the acquisition of Concert Pharmaceuticals, a developer of innovative medicine for patients with chronic diseases. For US$ 576 Million.

4) Pfizer Inc.

Pfizer Inc. is a pharmaceutical and biotechnology company based in America. It was founded in the year 1849. Pfizer manufactures and produces vaccines and medicine related to oncology, neurology, cardiology, and immunology. The corporation has produced various products that yield more than US$1 billion in annual revenue.

The company ranked 64^th on the Fortune 500 and 49^th on the Forbes Global 2000. The headquarters are located in New York City, U.S. and the products manufactured are sold worldwide. The company was founded by Charles Pfizer and Charles F. Erhart.

As of January 2023, Pfizer Inc. and Abzena have entered into an agreement under which Pfizer will be acquiring Abzena’s manufacturing facility in Sanford, North Carolina.

5) Merck & Co. Inc.

Merck, is a pharmaceutical institution based in America. The company’s headquarters are situated in Rahway, New Jersey. The company gets its name from Merck Group that was established in Germany in the year 1668. In the year 2022 the company ranked 71^st in the Fortune 500 companies list. And based on the revenues of 2021 it took the place as 87^th in the Forbes Global 2000.

In September 2022, Merck announced its plans of acquiring Vence, a livestock management company, incorporating it within Merck Animal Health.

6) AbbVie Inc.

AbbVie Inc. is a pharmaceutical company that manufactures products like Humira, Imbruvica, Venclexta, Norvir, Mavyret, Skyrizi, Rinvoq and others. AbbVie Inc. is ranked 6th on the list of largest biomedical companies by revenue. The company is also committed to product development for other treatments of cancer, neurologic diseases, eye care, and cystic fibrosis. AbbVie was founded in the year 2012, and the headquarters are located in North Chicago, Illinois, U.S.

In October 2022, the company acquired DJS Antibodies for U.S. $ 225 million, giving it access to an experimental drug for an aggressive lung disease as well as technology to develop certain antibody medicines.